In addition, we confirmed for the first time, to our knowledge, that lysosomal dysfunction might contribute to the CCH-induced activation of the NLRP3 inflammasome and subsequent release of IL-1β. This evidence concerns the gene IL1B and columnar cell hyperplasia of the breast.